Literature DB >> 26937033

Longitudinal Examination of the Intestinal Lamina Propria Cellular Compartment of Simian Immunodeficiency Virus-Infected Rhesus Macaques Provides Broader and Deeper Insights into the Link between Aberrant MicroRNA Expression and Persistent Immune Activation.

Vinay Kumar1, Workineh Torben1, Carys S Kenway1, Faith R Schiro1, Mahesh Mohan2.   

Abstract

UNLABELLED: Chronic immune activation/inflammation driven by factors like microbial translocation is a key determinant of human immunodeficiency virus/simian immunodeficiency virus (HIV/SIV) disease progression. Although extensive research on inflammation has focused on studying protein regulators, increasing evidence suggests a critical role for microRNAs (miRNAs) in regulating several aspects of the immune/inflammatory response and immune cell proliferation, differentiation, and activation. To understand their immunoregulatory role, we profiled miRNA expression sequentially in intestinal lamina propria leukocytes (LPLs) of eight macaques before and at 21, 90, and 180 days postinfection (dpi). At 21 dpi, ∼20 and 9 miRNAs were up- and downregulated, respectively. However, at 90 dpi (n = 60) and 180 dpi (n = 44), ≥75% of miRNAs showed decreased expression. Notably, the T-cell activation-associated miR-15b, miR-142-3p, miR-142-5p, and miR-150 expression was significantly downregulated at 90 and 180 dpi. Out of ∼10 downregulated miRNAs predicted to regulate CD69, we confirmed miR-92a to directly target CD69. Interestingly, the SIV-induced miR-190b expression was elevated at all time points. Additionally, elevated lipopolysaccharide (LPS)-responsive miR-146b-5p expression at 180 dpi was confirmed in primary intestinal macrophages following LPS treatment in vitro Further, reporter and overexpression assays validated IRAK1 (interleukin-1 receptor 1 kinase) as a direct miR-150 target. Furthermore, IRAK1 protein levels were markedly elevated in intestinal LPLs and epithelium. Finally, blockade of CD8(+) T-cell activation/proliferation with delta-9 tetrahydrocannabinol (Δ(9)-THC) significantly prevented miR-150 downregulation and IRAK1 upregulation. Our findings suggest that miR-150 downregulation during T-cell activation disrupts the translational control of IRAK1, facilitating persistent gastrointestinal (GI) inflammation. Finally, the ability of Δ(9)-THC to block the miR-150-IRAK1 regulatory cascade highlights the potential of cannabinoids to inhibit persistent inflammation/immune activation in HIV/SIV infection. IMPORTANCE: Persistent GI tract disease/inflammation is a cardinal feature of HIV/SIV infection. Increasing evidence points to a critical role for miRNAs in controlling several aspects of the immune/inflammatory response. Here, we show significant dysregulation of miRNA expression exclusively in the intestinal lamina propria cellular compartment through the course of SIV infection. Specifically, the study identified miRNA signatures associated with key pathogenic events, such as viral replication, T-cell activation, and microbial translocation. The T-cell-enriched miR-150 showed significant downregulation throughout SIV infection and was confirmed to target IRAK1, a critical signal-transducing component of the IL-1 receptor and TLR signaling pathways. Reduced miR-150 expression was associated with markedly elevated IRAK1 expression in the intestines of chronically SIV-infected macaques. Finally, Δ(9)-THC-mediated blockade of CD8(+) T-cell activation in vitro significantly inhibited miR-150 downregulation and IRAK1 upregulation, suggesting its potential for targeted immune modulation in HIV infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26937033      PMCID: PMC4859716          DOI: 10.1128/JVI.00189-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  CD69 is an immunoregulatory molecule induced following activation.

Authors:  David Sancho; Manuel Gómez; Francisco Sánchez-Madrid
Journal:  Trends Immunol       Date:  2005-03       Impact factor: 16.687

2.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

3.  miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.

Authors:  Endong Zhu; Xi Wang; Bin Zheng; Qian Wang; Jianlei Hao; Siming Chen; Qiang Zhao; Liqing Zhao; Zhenzhou Wu; Zhinan Yin
Journal:  J Immunol       Date:  2014-05-19       Impact factor: 5.422

4.  A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis.

Authors:  Jinpiao Lin; Rongfen Huo; Lianbo Xiao; Xianjin Zhu; Jun Xie; Songtao Sun; Yong He; Jie Zhang; Yue Sun; Zhou Zhou; Pinru Wu; Baihua Shen; Dangsheng Li; Ningli Li
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

5.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

6.  Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212.

Authors:  Md A Nahid; Bing Yao; Paul R Dominguez-Gutierrez; Lakshmyya Kesavalu; Minoru Satoh; Edward K L Chan
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

7.  Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Stephen Carney; Robert Crawford; Norbert E Kaminski
Journal:  Toxicology       Date:  2013-05-29       Impact factor: 4.221

8.  Early microbial translocation blockade reduces SIV-mediated inflammation and viral replication.

Authors:  Jan Kristoff; George Haret-Richter; Dongzhu Ma; Ruy M Ribeiro; Cuiling Xu; Elaine Cornell; Jennifer L Stock; Tianyu He; Adam D Mobley; Samantha Ross; Anita Trichel; Cara Wilson; Russell Tracy; Alan Landay; Cristian Apetrei; Ivona Pandrea
Journal:  J Clin Invest       Date:  2014-05-16       Impact factor: 14.808

9.  Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors:  Bruno Salaun; Takuya Yamamoto; Bassam Badran; Yasuko Tsunetsugu-Yokota; Antoine Roux; Lukas Baitsch; Redouane Rouas; Hussein Fayyad-Kazan; Petra Baumgaertner; Estelle Devevre; Anirudh Ramesh; Marion Braun; Daniel Speiser; Brigitte Autran; Philippe Martiat; Victor Appay; Pedro Romero
Journal:  J Transl Med       Date:  2011-04-20       Impact factor: 5.531

Review 10.  Expression, regulation and function of microRNAs in multiple sclerosis.

Authors:  Xinting Ma; Juhua Zhou; Yin Zhong; Linlin Jiang; Ping Mu; Yanmin Li; Narendra Singh; Mitzi Nagarkatti; Prakash Nagarkatti
Journal:  Int J Med Sci       Date:  2014-06-02       Impact factor: 3.738

View more
  17 in total

1.  miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Vinay Kumar; Joshua Mansfield; Rong Fan; Andrew MacLean; Jian Li; Mahesh Mohan
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

2.  PPRV-induced novel miR-3 contributes to inhibit type I IFN production by targeting IRAK1.

Authors:  Huan Li; Qinghong Xue; Yangli Wan; Yan Chen; Wei Zeng; Shaopeng Wei; Yanming Zhang; Jingyu Wang; Xuefeng Qi
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

Review 3.  Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.

Authors:  Rowan Saloner; Jerel Adam Fields; Maria Cecilia Garibaldi Marcondes; Jennifer E Iudicello; Sofie von Känel; Mariana Cherner; Scott L Letendre; Marcus Kaul; Igor Grant
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-15       Impact factor: 4.147

4.  Micro RNA Targets in HIV Latency: Insights into Novel Layers of Latency Control.

Authors:  Ashley I Heinson; Jeongmin Woo; Amey Mukim; Cory H White; Bastiaan Moesker; Alberto Bosque; Celsa A Spina; Christopher H Woelk; Ben D Macarthur; Nadejda Beliakova-Bethell
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-10       Impact factor: 2.205

Review 5.  Circulating microRNA-92a-3p in colorectal cancer: a review.

Authors:  Nami O Yamada; Takao Senda
Journal:  Med Mol Morphol       Date:  2021-02-23       Impact factor: 2.309

Review 6.  Cannabis and the Gut-Brain Axis Communication in HIV Infection.

Authors:  Natalie L Wilson; Scott N Peterson; Ronald J Ellis
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-15

7.  Evaluation of microRNA Expression in Patients with Herpes Zoster.

Authors:  Xihan Li; Ying Huang; Yucheng Zhang; Na He
Journal:  Viruses       Date:  2016-12-02       Impact factor: 5.048

Review 8.  Control of Immunoregulatory Molecules by miRNAs in T Cell Activation.

Authors:  Ana Rodríguez-Galán; Lola Fernández-Messina; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

9.  Identification of Host Micro RNAs That Differentiate HIV-1 and HIV-2 Infection Using Genome Expression Profiling Techniques.

Authors:  Krishnakumar Devadas; Santanu Biswas; Mohan Haleyurgirisetty; Viswanath Ragupathy; Xue Wang; Sherwin Lee; Indira Hewlett
Journal:  Viruses       Date:  2016-05-02       Impact factor: 5.048

10.  Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques.

Authors:  Xavier Alvarez; Karol Sestak; Siddappa N Byrareddy; Mahesh Mohan
Journal:  Viruses       Date:  2020-07-01       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.